| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.007 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |